Cargando…
Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine
BACKGROUND: Four of five Plasmodium species infecting humans are present in Madagascar. Plasmodium vivax remains the second most prevalent species, but is understudied. No data is available on its susceptibility to sulphadoxine-pyrimethamine, the drug recommended for intermittent preventive treatmen...
Autores principales: | Barnadas, Céline, Tichit, Magali, Bouchier, Christiane, Ratsimbasoa, Arsène, Randrianasolo, Laurence, Raherinjafy, Rogelin, Jahevitra, Martial, Picot, Stéphane, Ménard, Didier |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2268703/ https://www.ncbi.nlm.nih.gov/pubmed/18302746 http://dx.doi.org/10.1186/1475-2875-7-35 |
Ejemplares similares
-
Chloroquine Clinical Failures in P. falciparum Malaria Are Associated with Mutant Pfmdr-1, Not Pfcrt in Madagascar
por: Andriantsoanirina, Valérie, et al.
Publicado: (2010) -
Dihydrofolate Reductase I164L Mutation in Plasmodium falciparum, Madagascar
por: Ménard, Didier, et al.
Publicado: (2008) -
In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum
por: Andriantsoanirina, Valérie, et al.
Publicado: (2011) -
Management of uncomplicated malaria in febrile under five-year-old children by community health workers in Madagascar: reliability of malaria rapid diagnostic tests
por: Ratsimbasoa, Arsène, et al.
Publicado: (2012) -
Assessment of the efficacy of antimalarial drugs recommended by the National Malaria Control Programme in Madagascar: Up-dated baseline data from randomized and multi-site clinical trials
por: Ménard, Didier, et al.
Publicado: (2008)